Vertex Pharmaceuticals (VRTX) Other Working Capital Changes (2018 - 2019)

Vertex Pharmaceuticals' Other Working Capital Changes history runs 18 years deep, the most recent figure standing at -$173.4 million for Q1 2026.

• In Q1 2019, Other Working Capital Changes fell 8.07% year-over-year to $35.7 million; the TTM figure through Mar 2019 stood at $74.5 million (changed N/A YoY), while the FY2018 annual figure was $129.3 million, down 18.69% from the prior year.
• Other Working Capital Changes for Q1 2019 stood at $35.7 million, down from $38.8 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $38.8 million in Q1 2018, with the low at $35.7 million in Q1 2019.
• The 5-year median for Other Working Capital Changes is $40.9 million (2025), against an average of $76.2 million.
• The sharpest annual moves came in 2022 and 2026: Other Working Capital Changes soared 1889.31% in 2022, then tumbled 717.08% in 2026.
• Vertex Pharmaceuticals' Other Working Capital Changes stood at $38.8 million in 2018, then decreased by 8.07% to $35.7 million in 2019.
• Business Quant data shows VRTX's Other Working Capital Changes at $35.7 million in Q1 2019, $38.8 million in Q1 2018, and -$204000.0 in Q1 2011.